R. Naeije (Brussels, Belgium), P. Hassoun (Baltimore, Md, United States of America)
Expression and functional analysis of the transforming growth factor (TGF)-β superfamily in pulmonary arterial hypertension: role of PAI-1 in disease progression
F. M. Kouri, M. Queisser, R. Sandu, I. Chrobak, W. Klepetko, K. T. Preissner, W. Seeger, R. T. Schermuly, O. Eickelberg (Giessen, Germany)
|  |
Decreased expression of the TGF-beta type I receptor ALK1 in pulmonary arterial hypertension
O. Amarie, W. Klepetko, W. Seeger, N. Weissmann, O. Eickelberg (Giessen, Germany; Vienna, Austria)
|  |
Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension
F. Perros, P. Dorfmuller, R. Souza, D. Emilie, G. Simonneau, M. Humbert (Clamart, France)
| |
Gene expression alterations in mice lacking the VIP gene are conducive to pulmonary arterial hypertension and pulmonary vascular remodeling
S. Hamidi, S. Said (Stony Brook, NY, Northport, NY, United States Of America)
| |
Protection of vasoconstriction and lung function impairment by endothelin-receptor blockers and vasoactive intestinal peptide (VIP) in isolated perfused rat lungs
T. Janosi, F. Petak, M. Beghetti, D. Morel, W. Habre (Szeged, Hungary; Geneva, Switzerland)
| |
2-Ethoxyestradiol inhibits vascular and cardiac remodeling and attenuates monocrotaline-induced pulmonary hypertension
S. Tofovic, X. Zhang, H. Zhu, E. Jackson, G. Petrusevska (Pittsburgh, PA, United States Of America)
| |
Cytochrome c release from mitochondria in cardiomyocytes of pulmonary hypertensive patients
B. J. van Beek-Harmsen, F. de Man, J. W. M. Niessen, A. Boonstra, A. Vonk-Noordegraaf, W. J. van der Laarse (Amsterdam, Netherlands)
| |
Imbalanced type I TGF-β receptor signalling in the pulmonary vasculature: implications for the pathogenesis of bronchopulmonary dysplasia
M. Michiels-Corsten, A. Kumarasamy, M. Wygrecka, B. Eul, W. Seeger, O. Eickelberg, R. Morty (Giessen, Germany)
| |
Chemokine (C-C motif) ligand (CCL)-2 regulation by IL-13 in pulmonary arterial hypertension (PAH)
A. Zakrzewicz, M. Hecker, M. George, J. Wilhelm, W. Seeger, H. Ghofrani, O. Eickelberg (Giessen, Germany)
| |
Effects of selective and unselective endothelin-receptor antagonists on prostacyclin synthase gene expression in pulmonary hypertension
S. Schroll, M. Arzt, D. Sebah, B. Stoelcker, A. Luchner, F. C. Blumberg, M. Pfeifer (Regensburg, Donaustauf, Recklinghausen, Germany)
| |
Impairment of NO-dependent relaxation in rat intrapulmonary arteries by urban particulate matter
P. Andujar, A. Courtois, Y. Ladeiro, I. Baudrimont, P. Brochard, R. Marthan, B. Muller (Creteil, Bordeaux, France)
| |
Exhaled condensate of endothelin-1 and exhaled nitric oxide are increased in COPD patients with secondary pulmonary hypertension
P. Carratu, C. Scoditti, G. E. Carpagnano, M. Maniscalco, M. T. Seccia, G. Di Gioia, P. Pierucci, A. Spanevello, M. P. Foschino, O. Resta (Bari, Foggia, Naples, Italy)
| |
Classical transient receptor potential channel 6 (TRPC6) is a key regulator of acute hypoxic pulmonary vasoconstriction
N. Weissmann, B. Fuchs, M. Ay, R. Dumitrascu, H. Kalwa, A. Olschewski, M. Mederos y Schnitzler, U. Storch, A. Ghofrani, R. Schermuly, O. Pinkenburg, W. Seeger, F. Grimminger, T. Gudermann, A. Dietrich (Giessen, Marburg, Germany; Graz, Austria)
| |
Serum levels of vascular endothelial growth factor in patients with systemic sclerosis. Correlation with systolic pressure in the pulmonary artery
A. Papaioannou, Z. Daniil, E. Zakynthinos, K. Kostikas, A. Koutsokera, T. Kiropoulos, A. Ziogas, L. Sakkas, K. Gourgoulianis (Larissa, Greece)
| |
Relationship between oxidative stress, endothelial injury and coagulation activation in patients with chronic obstructive pulmonary disease
O. Korzh, S. Krasnokutskiy (Kharkov, Ukraine)
| |
Anti-endothelial cell antibodies in patients with COPD
L. Taraseviciene-Stewart, V. Kraskauskiene, N. Burns, N. Voelkel (Denver, CO, United States Of America)
| |
Hypoxia-dependent regulation of non-phagocytic NADPH oxidase NOX4 in the pulmonary vasculature
M. Mittal, M. Roth, P. Koenig, S. Hofmann, E. Dony, P. Goyal, A. C. Selbitz, R. T. Schermuly, H. A. Ghofrani, G. Kwapiszewska, W. Kummer, W. Klepetko, M. A. Reza Hoda, L. Fink, J. Haenze, W. Seeger, F. Grimminger, H. H. H. W. Schmidt, N. Weissmann (Giesse
| |
The relationships between PAC-1, CD62P and pulmonary hypertension in chronic obstructive pulmonary disease
Y. Zhou, H. Huang, Y. Wu, Y. Yan (Guangzhou, China)
| |
Circulating endothelial progenitor cells in COPD: effect of pulmonary hypertension
S. Pizarro, M. Diez, V. I. Peinado, Y. Torralba, V. Delgado, J. Petriz, M. Sitges, P. Marín, M. T. Melgosa, J. Roca, J. A. Barberà (Barcelona, Spain)
| |
Redox state of mitochondrial cytochromes in isolated lungs and pulmonary arterial smooth muscle cells during acute and prolonged hypoxia
N. Sommer, A. Ghofrani, R. Schermuly, W. Seeger, F. Grimminger, N. Weissmann (Giessen, Germany)
| |